Whole-Genome Sequence of Stenotrophomonas maltophilia D457, a Clinical Isolate and a Model Strain

Stenotrophomonas maltophilia is an opportunistic pathogen with an environmental origin, and it is an increasingly relevant cause of nosocomial infections. Here we present the whole-genome sequence of S. maltophilia strain D457, a clinical isolate that is being used as a model for studying antibiotic...

Full description

Saved in:
Bibliographic Details
Published inJournal of Bacteriology Vol. 194; no. 13; pp. 3563 - 3564
Main Authors Lira, Felipe, Hernández, Alvaro, Belda, Eugeni, Sánchez, María B, Moya, Andrés, Silva, Francisco J, Martínez, José L
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.07.2012
Subjects
Anti-Bacterial Agents - pharmacology
antibiotic resistance
Antibiotics
Bacteria
Bacteriology
Biological and medical sciences
Drug resistance
Drug Resistance, Bacterial
Fundamental and applied biological sciences. Psychology
Genes, Bacterial
genome
Genome Announcements
Genome, Bacterial
Genomes
Gram-Negative Bacterial Infections - microbiology
Humans
Microbiology
Miscellaneous
Nosocomial infections
nucleotide sequences
pathogens
Sequence Analysis, DNA
Stenotrophomonas maltophilia
Stenotrophomonas maltophilia - classification
Stenotrophomonas maltophilia - drug effects
Stenotrophomonas maltophilia - genetics
Stenotrophomonas maltophilia - isolation & purification
Pseudomonadales
Stenotrophomonas maltophilia
Nucleotide sequence
Bacteria
Pseudomonadaceae
Models
Clinical isolate
Strain
Online AccessGet full text

Cover

More Information
Summary:Stenotrophomonas maltophilia is an opportunistic pathogen with an environmental origin, and it is an increasingly relevant cause of nosocomial infections. Here we present the whole-genome sequence of S. maltophilia strain D457, a clinical isolate that is being used as a model for studying antibiotic resistance in this bacterial species.
Bibliography:http://dx.doi.org/10.1128/JB.00602-12
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Present address: Alvaro Hernández, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada; Eugeni Belda, CEA-Genoscope, Laboratoire d'Analyse Bioinformatique en Génomique et Métabolisme, Evry, France.
ISSN:0021-9193
1098-5530
1067-8832
DOI:10.1128/JB.00602-12